2013
DOI: 10.1097/tp.0b013e3182a3df74
|View full text |Cite
|
Sign up to set email alerts
|

Effect of a Novel Nuclear Factor-κB Activation Inhibitor on Renal Ischemia-Reperfusion Injury

Abstract: Treatment with DHMEQ before renal artery clamping may therefore be useful for renal I/R injury and application to renal transplantation is expected.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(18 citation statements)
references
References 30 publications
1
16
0
1
Order By: Relevance
“…[8288]. In addition, ROS has been reported to participate in NF-κB pathway activation, which is unsurprising given the oxidant-sensitive properties of NF-κB [86].…”
Section: Discussionmentioning
confidence: 99%
“…[8288]. In addition, ROS has been reported to participate in NF-κB pathway activation, which is unsurprising given the oxidant-sensitive properties of NF-κB [86].…”
Section: Discussionmentioning
confidence: 99%
“…Inflammation is invariably found to be an important initiating and aggravating factor in both acute and chronic kidney injury ( 13 ). Nuclear factor-κB (NF-κB), a pivotal mediator of the inflammatory response, modulates the expression levels of adhesion molecules, chemokines and other pro-inflammatory molecules in the kidney ( 14 , 15 ). It was reported that interleukin (IL)-4 promoted the activation of signal transducer and activator of transcription 6 (STAT6), suppressing the transcriptional activation of NF-κB-dependent proinflammatory mediators following liver IRI ( 16 , 17 ).…”
Section: Introductionmentioning
confidence: 99%
“…Inflammation is an invariable finding in acute and chronic kidney injury ( 12 ) and is a critical initiating and aggravating factor in kidney damage ( 13 ). A pivotal mediator of this inflammatory response is the transcription factor nuclear factor-κB (NF-κB), which regulates the expression of adhesion molecules, chemokines and other pro-inflammatory molecules in renal or endothelial cells (ECs) ( 14 16 ). The best-characterized signaling pathways that lead to NF-κB activation are those stimulated by members of the interleukin-1 (IL-1)/Toll-like receptor family and tumor necrosis factor-α (TNF-α) ( 17 ).…”
Section: Introductionmentioning
confidence: 99%